Dollars for Docs
How Industry Dollars Reach Your Doctors
This database was last updated in October 2019 and should only be used as a historical snapshot. Newer data is available at the Centers for Medicare and Medicaid Services Open Payments site.
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.
MATTHEW S DAVIDS
Listed Specialty: Hematology & Oncology
450 BROOKLINE AVE, BOSTON, MA, 02215-5418
Is this you? Do you believe the data contains errors? Click here for information →
Is This Your Doctor?
Print out this record, along with questions and tips for talking with your physician about payments.
Have you used or plan to use this information? Tell us about it.
MATTHEW DAVIDS,
Yearly Payment Breakdown:
2018 Payments At a Glance
89
payments
$103,217
payment total
10
companies paid this doctor
Payment Calendar in 2018
This doctor received a payment on days in 2018.
Each box below represents a single day during the disclosure period. A gray box indicates no payments. The darker the color, the more payments a doctor received that day.
2018
Types of Payments in 2018
| Category | Payments | Payment Value |
|---|---|---|
Consulting |
19 | $68,170 |
Travel and Lodging |
32 | $33,280 |
Food and Beverage |
38 | $1,767 |
Drugs & Devices in 2018
Totals listed below account for all payments from that mention this product. Beginning in 2016, the government began classifying products as drugs, devices, biologics or medical supplies. Below, you will see drugs (drugs and biologics) and devices (devices and medical supplies). If a payment record mentions more than one product, the entire value will be included in each of those products. When no products are listed, they are not included in the list below.
| Product Name | Product Type | Payments† |
|---|---|---|
VENCLEXTA |
drug |
$35,983 |
IMBRUVICA |
drug |
$21,078 |
CALQUENCE |
drug |
$17,525 |
Payments with no listed product |
N/A |
$13,450 |
NON-COVERED PRODUCT |
drug |
$8,000 |
VENCLEXTA |
drug |
$4,916 |
RITUXAN |
drug |
$4,232 |
ZYDELIG |
drug |
$2,265 |
| † May not add up to dollar total at top of page, since a payment record may not be associated with any product or can be associated with several products. | ||
Payment Details in 2018
| When | How Much | Related To | What For | From | Third Party Payee |
|---|---|---|---|---|---|
| Nov 17, 2018 | $11,683 | VENCLEXTA | Travel and Lodging | ABBVIE, INC. | |
| Sep 20, 2018 | $8,195 | CALQUENCE | Travel and Lodging | ACERTA PHARMA LLC | |
| Feb 7, 2018 | $8,000 | NON-COVERED PRODUCT | Consulting | GENENTECH USA, INC. | |
| Jun 12, 2018 | $7,466 | VENCLEXTA | Travel and Lodging | ABBVIE, INC. | |
| Aug 1, 2018 | $6,600 | VENCLEXTA | Consulting | ABBVIE, INC. | |
| Nov 16, 2018 | $6,000 | No Listed Product | Consulting | ABBVIE, INC. | |
| May 29, 2018 | $6,000 | No Listed Product | Consulting | ABBVIE, INC. | |
| Jun 29, 2018 | $5,500 | IMBRUVICA | Consulting | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Feb 8, 2018 | $4,800 | VENCLEXTA | Consulting | ABBVIE, INC. | |
| Apr 9, 2018 | $4,028 | CALQUENCE | Consulting | ASTRAZENECA PHARMACEUTICALS LP | |
| Oct 12, 2018 | $3,500 | RITUXAN VENCLEXTA | Consulting | GENENTECH, INC. | |
| Oct 3, 2018 | $3,500 | CALQUENCE | Consulting | ACERTA PHARMA LLC | |
| Dec 20, 2018 | $3,175 | IMBRUVICA | Consulting | JANSSEN GLOBAL SERVICES, LLC | |
| May 1, 2018 | $3,000 | IMBRUVICA | Consulting | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Jan 18, 2018 | $3,000 | IMBRUVICA | Consulting | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Jan 3, 2018 | $2,540 | IMBRUVICA | Consulting | JANSSEN GLOBAL SERVICES, LLC | |
| May 6, 2018 | $2,000 | ZYDELIG | Consulting | GILEAD SCIENCES INC | |
| Aug 20, 2018 | $1,800 | VENCLEXTA | Consulting | ABBVIE, INC. | |
| Mar 30, 2018 | $1,600 | VENCLEXTA | Consulting | ABBVIE, INC. | |
| Oct 31, 2018 | $1,500 | IMBRUVICA | Consulting | JANSSEN BIOTECH, INC. | |
| Jul 31, 2018 | $1,074 | CALQUENCE | Consulting | ASTRAZENECA PHARMACEUTICALS LP | |
| Jan 24, 2018 | $568 | No Listed Product | Travel and Lodging | GENENTECH USA, INC. | |
| Sep 30, 2018 | $553 | VENCLEXTA | Consulting | F. HOFFMANN-LA ROCHE AG | |
| Oct 12, 2018 | $536 | RITUXAN VENCLEXTA | Travel and Lodging | GENENTECH, INC. | |
| Mar 22, 2018 | $453 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Aug 1, 2018 | $450 | VENCLEXTA | Travel and Lodging | ABBVIE, INC. | |
| Nov 29, 2018 | $393 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Jun 1, 2018 | $383 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Feb 8, 2018 | $321 | VENCLEXTA | Travel and Lodging | ABBVIE, INC. | |
| Jan 24, 2018 | $299 | No Listed Product | Travel and Lodging | GENENTECH USA, INC. | |
| Sep 20, 2018 | $267 | CALQUENCE | Travel and Lodging | ACERTA PHARMA LLC | |
| Jan 24, 2018 | $258 | No Listed Product | Travel and Lodging | GENENTECH USA, INC. | |
| Jun 13, 2018 | $246 | VENCLEXTA | Travel and Lodging | ABBVIE, INC. | |
| Sep 20, 2018 | $229 | CALQUENCE | Travel and Lodging | ACERTA PHARMA LLC | |
| Nov 16, 2018 | $228 | VENCLEXTA | Travel and Lodging | ABBVIE, INC. | |
| Mar 23, 2018 | $200 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Feb 8, 2018 | $161 | VENCLEXTA | Travel and Lodging | ABBVIE, INC. | |
| Jun 1, 2018 | $149 | ZYDELIG | Travel and Lodging | GILEAD SCIENCES INC | |
| May 31, 2018 | $149 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| May 29, 2018 | $137 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| Nov 29, 2018 | $119 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Jun 13, 2018 | $118 | VENCLEXTA | Food and Beverage | ABBVIE, INC. | |
| Oct 13, 2018 | $117 | RITUXAN VENCLEXTA | Food and Beverage | GENENTECH, INC. | |
| Jan 22, 2018 | $117 | VENCLEXTA | Food and Beverage | GENENTECH USA, INC. | |
| Jan 19, 2018 | $111 | VENCLEXTA | Food and Beverage | ABBVIE, INC. | |
| Nov 16, 2018 | $102 | No Listed Product | Travel and Lodging | ABBVIE, INC. | |
| Nov 30, 2018 | $88 | VENCLEXTA | Food and Beverage | ABBVIE, INC. | |
| Sep 20, 2018 | $85 | CALQUENCE | Travel and Lodging | ACERTA PHARMA LLC | |
| Mar 22, 2018 | $78 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| May 1, 2018 | $70 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Jun 14, 2018 | $62 | VENCLEXTA | Travel and Lodging | ABBVIE, INC. | |
| Jul 16, 2018 | $58 | CALQUENCE | Food and Beverage | ASTRAZENECA PHARMACEUTICALS LP | |
| Mar 23, 2018 | $56 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Jul 17, 2018 | $53 | VENCLEXTA | Food and Beverage | ABBVIE, INC. | |
| Mar 23, 2018 | $52 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Jun 1, 2018 | $50 | ZYDELIG | Food and Beverage | GILEAD SCIENCES INC | |
| Jun 1, 2018 | $50 | ZYDELIG | Food and Beverage | GILEAD SCIENCES INC | |
| May 1, 2018 | $50 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Jun 1, 2018 | $48 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Jan 24, 2018 | $47 | No Listed Product | Food and Beverage | GENENTECH USA, INC. | |
| Feb 8, 2018 | $46 | VENCLEXTA | Food and Beverage | ABBVIE, INC. | |
| Oct 12, 2018 | $46 | RITUXAN VENCLEXTA | Food and Beverage | GENENTECH, INC. | |
| May 1, 2018 | $46 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Nov 29, 2018 | $45 | VENCLEXTA | Food and Beverage | ABBVIE, INC. | |
| Nov 20, 2018 | $45 | VENCLEXTA | Food and Beverage | ABBVIE, INC. | |
| Mar 23, 2018 | $42 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Nov 16, 2018 | $41 | VENCLEXTA | Food and Beverage | ABBVIE, INC. | |
| Dec 4, 2018 | $39 | IMBRUVICA | Food and Beverage | JANSSEN GLOBAL SERVICES, LLC | |
| Sep 20, 2018 | $37 | CALQUENCE | Food and Beverage | ACERTA PHARMA LLC | |
| Sep 20, 2018 | $37 | CALQUENCE | Food and Beverage | ACERTA PHARMA LLC | |
| Jun 1, 2018 | $36 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Oct 12, 2018 | $32 | RITUXAN VENCLEXTA | Travel and Lodging | GENENTECH, INC. | |
| Nov 29, 2018 | $32 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Nov 29, 2018 | $31 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Dec 1, 2018 | $29 | No Listed Product | Food and Beverage | ABBVIE, INC. | |
| Mar 23, 2018 | $23 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Jun 1, 2018 | $21 | IMBRUVICA | Food and Beverage | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| Sep 20, 2018 | $15 | CALQUENCE | Food and Beverage | ACERTA PHARMA LLC | |
| Jan 22, 2018 | $15 | VENCLEXTA | Food and Beverage | GENENTECH USA, INC. | |
| Dec 4, 2018 | $14 | IMBRUVICA | Food and Beverage | JANSSEN GLOBAL SERVICES, LLC | |
| Nov 16, 2018 | $10 | VENCLEXTA | Food and Beverage | ABBVIE, INC. | |
| Nov 16, 2018 | $10 | VENCLEXTA | Food and Beverage | ABBVIE, INC. | |
| Nov 29, 2018 | $10 | IMBRUVICA | Food and Beverage | JANSSEN GLOBAL SERVICES, LLC | |
| Jan 24, 2018 | $9 | No Listed Product | Travel and Lodging | GENENTECH USA, INC. | |
| Jun 1, 2018 | $8 | ZYDELIG | Food and Beverage | GILEAD SCIENCES INC | |
| Jun 1, 2018 | $8 | ZYDELIG | Food and Beverage | GILEAD SCIENCES INC | |
| May 1, 2018 | $7 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| May 1, 2018 | $7 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY | |
| May 1, 2018 | $5 | IMBRUVICA | Travel and Lodging | PHARMACYCLICS LLC, AN ABBVIE COMPANY |
See this doctor’s Open Payments page →
Note: We have made some effort to normalize the data and eliminate duplicates, but the data is primarily as it has been reported by the companies to the Centers for Medicare and Medicaid Services. To purchase the normalized data, please visit the ProPublica Data Store. If you spot an error, please let us know at [email protected].
This site includes data published by the Centers for Medicare and Medicaid Services on June 28, 2019.